Wolverine Trading, LLC Ionis Pharmaceuticals Inc Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $128,192 - $165,952	-3,200 Reduced 14.75%	18,500 $741,000
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $444,690 - $581,940	12,200 Added 128.42%	21,700 $1.03 Million
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $96,669 - $123,165	2,300 Added 31.94%	9,500 $411,000
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $151,865 - $180,705	-3,500 Reduced 32.71%	7,200 $364,000
Q3 2023 Nov 15, 2023	BUY	$38.5 - $47.13 $411,950 - $504,291	10,700 New	10,700 $485,000
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $371,200 - $465,200	10,000 New	10,000 $378,000
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $361,494 - $490,200	-11,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $29,880 - $37,040	1,000 Added 9.62%	11,400 $407,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $417,443 - $572,130	-16,300 Reduced 61.05%	10,400 $318,000
Q2 2021 Aug 06, 2021	BUY	$34.54 - $47.25 $107,074 - $146,475	3,100 Added 13.14%	26,700 $1.06 Million
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $1.18 Million - $1.77 Million	-27,700 Reduced 54.0%	23,600 $1.06 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $1.78 Million - $2.37 Million	39,300 Added 327.5%	51,300 $2.93 Million
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $218,270 - $289,570	-4,600 Reduced 27.71%	12,000 $582,000
Q2 2020 Aug 13, 2020	SELL	$46.85 - $61.05 $313,895 - $409,035	-6,700 Reduced 28.76%	16,600 $986,000
Q1 2020 May 11, 2020	SELL	$41.6 - $63.4 $1.82 Million - $2.77 Million	-43,700 Reduced 65.22%	23,300 $1.12 Million
Q4 2019 Feb 12, 2020	BUY	$53.85 - $65.27 $118,470 - $143,594	2,200 Added 3.4%	67,000 $4.04 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $159,462 - $194,805	2,700 Added 4.35%	64,800 $3.83 Million
Q2 2019 Aug 20, 2019	SELL	$62.09 - $86.14 $701,617 - $973,382	-11,300 Reduced 15.4%	62,100 $3.99 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $2.45 Million - $3.76 Million	46,300 Added 170.85%	73,400 $5.96 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $1.84 Million - $2.53 Million	-42,500 Reduced 61.06%	27,100 $1.39 Million
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $145,792 - $182,580	-3,400 Reduced 4.66%	69,600 $3.59 Million
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $405,536 - $506,460	9,200 Added 14.42%	73,000 $3.22 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $5,030 - $6,439	-100 Reduced 0.16%	63,800 $3.21 Million
Q3 2017 Nov 15, 2017	BUY	$45.56 - $59.57 $2.91 Million - $3.81 Million	63,900	63,900 $3.24 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$550 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$518 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$377 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$319 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$288 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account